AT
AZN icon

Arden Trust’s AstraZeneca AZN Stock Holding History

Arden Trust’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,375
Closed -$123K – 356
2020
Q1 		$123K Buy
+1,375
New +$129K 0.02% 353
2018
Q4 		– Sell
-2,715
Closed -$215K – 326
2018
Q3 		$215K Sell
2,715
-314
-10% -$23.8K 0.03% 346
2018
Q2 		$213K Sell
3,029
-790
-21% -$56.8K 0.03% 341
2018
Q1 		$267K Sell
3,819
-388
-9% -$26.9K 0.04% 317
2017
Q4 		$292K Buy
4,207
+41
+1% +$2.77K 0.04% 296
2017
Q3 		$282K Buy
4,166
+288
+7% +$18.2K 0.04% 303
2017
Q2 		$265K Sell
3,878
-95
-2% -$6.2K 0.04% 315
2017
Q1 		$247K Buy
3,973
+165
+4% +$9.61K 0.04% 309
2016
Q4 		$208K Sell
3,808
-3,789
-50% -$215K 0.03% 323
2016
Q3 		$500K Sell
7,597
-15,526
-67% -$1.01M 0.08% 224
2016
Q2 		$1.4M Buy
23,123
+2,893
+14% +$168K 0.11% 193
2016
Q1 		$1.14M Sell
20,230
-9,134
-31% -$549K 0.09% 222
2015
Q4 		$1.99M Sell
29,364
-408
-1% -$26.8K 0.17% 139
2015
Q3 		$1.89M Buy
29,772
+11,659
+64% +$767K 0.16% 155
2015
Q2 		$1.15M Buy
18,113
+2,027
+13% +$139K 0.17% 152
2015
Q1 		$1.1M Buy
16,086
+4,033
+33% +$280K 0.16% 167
2014
Q4 		$848K Sell
12,053
-5
-0% -$358 0.12% 173
2014
Q3 		$862K Sell
12,058
-363
-3% -$26.6K 0.12% 169
2014
Q2 		$923K Buy
12,421
+3,062
+33% +$221K 0.13% 149
2014
Q1 		$608K Buy
9,359
+5,420
+138% +$350K 0.07% 210
2013
Q4 		$234K Buy
+3,939
New +$214K 0.03% 289

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

Arden Trust's AZN Position: Q2 2020 in Review

Arden Trust sold out of AstraZeneca (AZN) in Q2 2020, closing a stake of 1,375 shares — an estimated $123K sold.

Arden Trust first reported a position in AZN in Q4 2013 and held it in 21 quarters. The position peaked at $1.99M in Q4 2015. 669 funds tracked by Wall St. Rank hold AZN as of Q2 2020.

  • Arden Trust reported no remaining AstraZeneca position as of Q2 2020 after selling out during the quarter.
  • Arden Trust sold 1,375 AstraZeneca shares in Q2 2020, an estimated $123K.
  • Arden Trust first reported a position in AstraZeneca in Q4 2013 and held it in 21 quarters.
  • Arden Trust's AstraZeneca position peaked at $1.99M in Q4 2015.
  • 669 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2020.

Based on Arden Trust's 13F filing for Q2 2020, filed 9 Jul 2020.